Mia Wadelius

Mia Wadelius

UNVERIFIED PROFILE

Are you Mia Wadelius?   Register this Author

Register author
Mia Wadelius

Mia Wadelius

Publications by authors named "Mia Wadelius"

Are you Mia Wadelius?   Register this Author

70Publications

2033Reads

50Profile Views

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture.

Calcif Tissue Int 2019 Jul 20;105(1):51-67. Epub 2019 Apr 20.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00223-019-00546-9
Publisher Site
http://dx.doi.org/10.1007/s00223-019-00546-9DOI Listing
July 2019

Fusidic Acid: A Neglected Risk Factor for Statin-Associated Myopathy.

Clin Med Insights Cardiol 2018 4;12:1179546818815162. Epub 2018 Dec 4.

Uppsala University Hospital and Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179546818815162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299330PMC
December 2018

Clinical factors predicting drug-induced liver injury due to flucloxacillin.

Drug Healthc Patient Saf 2018 21;10:95-101. Epub 2018 Nov 21.

Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DHPS.S178394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254585PMC
November 2018

Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia.

Circ Cardiovasc Genet 2017 Aug;10(4)

From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M.P., A.A.); Department of Medical Sciences, Clinical Pharmacology and Science of Life Laboratory, Uppsala University, Sweden (M.W.); Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, The Netherlands (A.H.M.v.d.Z.); Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.); Brigham and Women's Hospital and Harvard Medical School, Boston, MA (P.M.R., D.I.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCGENETICS.117.001737DOI Listing
August 2017

[Preventive work can reduce drug side effects].

Lakartidningen 2017 07 14;114. Epub 2017 Jul 14.

- Uppsala, Sweden Uppsala universitet - Institutionen för medicinska vetenskaper Uppsala, Sweden.

View Article

Download full-text PDF

Source
July 2017

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.

Pharmacogenomics 2017 Feb 13;18(3):201-213. Epub 2017 Jan 13.

Department of Medical Sciences, Clinical Pharmacology & Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2016-0184DOI Listing
February 2017

Influence of APOE Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement: A Systematic Review and Meta-Analysis.

Cardiovasc Ther 2016 Oct;34(5):297-307

Center of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1755-5922.12186DOI Listing
October 2016

Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose.

Pharmacogenomics 2016 08 5;17(12):1305-14. Epub 2016 Feb 5.

Department of Medical Sciences & Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2015-0013DOI Listing
August 2016

Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants.

Thromb Res 2015 Jul 25;136(1):69-75. Epub 2015 Apr 25.

The Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2015.04.026DOI Listing
July 2015

Oral anticoagulation: a critique of recent advances and controversies.

Trends Pharmacol Sci 2015 Mar 17;36(3):153-63. Epub 2015 Feb 17.

Uppsala University, 751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tips.2015.01.003DOI Listing
March 2015

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children.

BMC Med Inform Decis Mak 2015 Feb 7;15. Epub 2015 Feb 7.

Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, SE-751 85, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12911-014-0128-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324411PMC
February 2015

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients.

Expert Opin Drug Saf 2014 Oct 18;13(10):1305-17. Epub 2014 Aug 18.

University of British Columbia (UBC), Neuroscience Program , Room S178, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 2B5 , Canada +1 604 822 0759 ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14740338.2014.94
Publisher Site
http://dx.doi.org/10.1517/14740338.2014.947958DOI Listing
October 2014

Warfarin pharmacogenetics: it matters if you're black or white.

Authors:
Mia Wadelius

Blood 2014 Oct;124(14):2171

UPPSALA UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-08-594119DOI Listing
October 2014

Characterizing variability in warfarin dose requirements in children using modelling and simulation.

Br J Clin Pharmacol 2014 Jul;78(1):158-69

Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168390PMC
July 2014

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

J Clin Oncol 2014 Apr 3;32(10):1031-9. Epub 2014 Mar 3.

Dan Rosmarin, Claire Palles, David Church, Enric Domingo, Angela Jones, Ian Tomlinson, Wellcome Trust Centre for Human Genetics, NIHR Comprehensive Biomedical Research Centre, University of Oxford; Dan Rosmarin, David Church, Elaine Johnstone, Haitao Wang, Sharon Love, Patrick Julier, Claire Scudder, George Nicholson, Rachel Midgley, David Kerr, and George Nicholson, University of Oxford, Oxford; Michael Braun, The Christie NHS Foundation Trust, Manchester; Matthew Seymour, St James's University Hospital, Leeds; Lindsay Thompson, Medical Research Council Clinical Trials Unit; Rohini Sharma, Imperial College Healthcare NHS Trust, Hammersmith and Charing Cross Hospitals, London, United Kingdom; Anna Gonzalez-Neira, Spanish National Cancer Research Centre; Miguel Martin, Instituto de Investigacion Sanitaria Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid; Nuria Ribelles, Hospital Universitario Virgen de la Victoria, Málaga; Eva Martinez-Balibrea, Institut Català d'Oncologia, Institut de Recerca Sanitària Germans Trias i Pujol, Barcelona; Jesus Garcia-Foncillas, University Clinic of Navarra, University of Navarra, Pamplona, Spain; Daniel Sargent, Erin Green, Mayo Clinic, Rochester, MN; Howard McLeod, University of North Carolina, Chapel Hill, NC; Ulrich M. Zanger, Matthias Schwab, Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart; Ulrich M. Zanger, Matthias Schwab, University Hospital Tuebingenl, Tuebingen, Germany; Benjamin Lacas, Valérie Boige, Jean-Pierre Pignon, Institut Gustave Roussy, Villejuif; Marie-Christine Etienne-Grimaldi, Gérard Milano, Centre Antoine Lacassagne, Nice; Thierry Lecomte, Pierre Laurent-Puig, Assistance Publique Hopitaux de Paris, Hopital Européen Georges Pompidou, Paris; Alain Morel, Institut National de la Sante et de la Recherche Medicale U564, Centre Paul Papin, Angers, France; Shoaib Afzal, Henrik Enghusen, Laboratory of Clinical Pharmacology, Rigshospitalet, Copenhagen; Sør

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.1857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879695PMC
April 2014

Pharmacogenetics-based warfarin dosing in children.

Pharmacogenomics 2014 Feb;15(3):361-74

Department of Medical Sciences, Division of Clinical Pharmacology, Uppsala University, SE-751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pgs.14.8
Publisher Site
http://dx.doi.org/10.2217/pgs.14.8DOI Listing
February 2014

A randomized trial of genotype-guided dosing of warfarin.

N Engl J Med 2013 Dec 19;369(24):2294-303. Epub 2013 Nov 19.

From the University of Liverpool (M.P., G.B., A.L.J., C.H.T., J.E.Z., P.R.W.) and Royal Liverpool and Broadgreen University Hospital National Health Service (NHS) Trust (M.P., C.H.T.), Liverpool, Whiston Hospital, Prescot (T.N.), and Newcastle upon Tyne NHS Trust (P.K.) and Newcastle University (J.B.L., A.K.D., P.A., F.K.), Newcastle upon Tyne - all in the United Kingdom; Uppsala University, Department of Medical Sciences (N.E., C.C., H.K., M.W.), Uppsala Clinical Research Center (N.E.) and Uppsala University Hospital (C.C., B.W., M.W.), Uppsala, and Enköping Hospital, Enköping (C.S.) - all in Sweden; and Utrecht University, Utrecht, the Netherlands (A.H.M.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311386DOI Listing
December 2013

[Pharmacogenetic analysis can predict adverse effects of statins].

Lakartidningen 2013 May 7-21;110(19-20):951-2

Klinisk kemi och farmakologi, Akademiska sjukhuset, Uppsala.

View Article

Download full-text PDF

Source
July 2013

Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithms.

Eur J Clin Pharmacol 2013 Jun 11;69(6):1275-83. Epub 2013 Jan 11.

Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Entrance 61 3rd floor, SE-751 85, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-012-1466-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651819PMC
June 2013

Prediction of warfarin dose: why, when and how?

Pharmacogenomics 2012 Mar;13(4):429-40

Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala University Hospital, entrance 61, SE-751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.11.184DOI Listing
March 2012

Pharmacogenomics and personalized medicine: the plunge into next-generation sequencing.

Genome Med 2011 Dec 28;3(12):78. Epub 2011 Dec 28.

Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala University Hospital, entrance 61, SE-751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334543PMC
December 2011

Point: use of pharmacogenetics in guiding treatment with warfarin.

Authors:
Mia Wadelius

Clin Chem 2009 Apr 30;55(4):709-11. Epub 2009 Jan 30.

Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://www.clinchem.org/cgi/doi/10.1373/clinchem.2008.115964
Publisher Site
http://dx.doi.org/10.1373/clinchem.2008.115964DOI Listing
April 2009

The largest prospective warfarin-treated cohort supports genetic forecasting.

Blood 2009 Jan 23;113(4):784-92. Epub 2008 Jun 23.

Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-04-149070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630264PMC
January 2009

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.

J Psychiatr Res 2008 Sep 20;42(11):884-93. Epub 2007 Dec 20.

Department of Pharmaceutical Biosciences, University of Uppsala, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2007.10.007DOI Listing
September 2008

Placental transfer of quetiapine in relation to P-glycoprotein activity.

J Psychopharmacol 2007 Sep 26;21(7):751-6. Epub 2007 Jan 26.

Department of Pharmacology and Clinical Pharmacology, Joint Clinical Biochemistry Laboratory of University of Turku, Turku University Central Hospital, Turku, Finland.

View Article

Download full-text PDF

Source
http://jop.sagepub.com/content/early/2007/01/26/026988110607
Web Search
http://jop.sagepub.com/cgi/doi/10.1177/0269881106074065
Publisher Site
http://dx.doi.org/10.1177/0269881106074065DOI Listing
September 2007

Association of warfarin dose with genes involved in its action and metabolism.

Hum Genet 2007 Mar 18;121(1):23-34. Epub 2006 Oct 18.

Department of Medical Sciences, Clinical Pharmacology, University Hospital, 751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-006-0260-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797064PMC
March 2007

Possible fluconazole-fentanyl interaction-a case report.

Eur J Clin Pharmacol 2006 Jun 21;62(6):491-2. Epub 2006 Apr 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-006-0120-4DOI Listing
June 2006

Apolipoprotein E (APOE) and warfarin dosing in an Italian population.

Eur J Clin Pharmacol 2005 Nov 26;61(10):781-3. Epub 2005 Aug 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-005-0982-xDOI Listing
November 2005

Functional role of P-glycoprotein in the human blood-placental barrier.

Clin Pharmacol Ther 2005 Aug;78(2):123-31

Department of Pharmacology and Clinical Pharmacology, University of Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clpt.2005.04.014DOI Listing
August 2005

Warfarin dose related to apolipoprotein E (APOE) genotype.

Eur J Clin Pharmacol 2005 Jul 11;61(5-6):381-8. Epub 2005 Jun 11.

Department of Medical Sciences, Clinical Pharmacology, University Hospital, 75185, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-005-0936-3DOI Listing
July 2005

Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?

BMC Blood Disord 2004 Dec 2;4(1). Epub 2004 Dec 2.

Department of Medical Sciences, Uppsala University, Uppsala University Hospital S- 751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2326-4-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC535939PMC
December 2004

CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartum.

Nord J Psychiatry 2004 ;58(1):61-4

Division of Obstetrics and Gynecology, Department of Molecular and Clinical Medicine, University Hospital, Lnköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08039480310000815DOI Listing
May 2004

Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy.

Pharmacol Toxicol 2003 Jun;92(6):295-9

Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0773.2003.920607.xDOI Listing
June 2003

Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technology.

Assay Drug Dev Technol 2002 Nov;1(1 Pt 1):49-59

Pyrosequencing AB, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/154065802761001301DOI Listing
November 2002

5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.

Pharmacogenetics 2002 Jun;12(4):307-12

Department of Medical Sciences, Clinical Pharmacology, University Hospital, S-751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00008571-200206000-00006DOI Listing
June 2002